We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RC
2251
Ready Capital
RC
$308M
$3.94M ﹤0.01%
293,164
+114,869
+64% +$1.49M
MRSN
2252
DELISTED
Mersana Therapeutics
MRSN
$3.92M ﹤0.01%
9,697
-6,145
-39% -$2.98M
TBPH icon
2253
Theravance Biopharma
TBPH
$877M
$3.92M ﹤0.01%
191,887
+1,727
+0.9% +$32.8K
ECHO
2254
EchoStar
ECHO
$26.2B
$3.91M ﹤0.01%
162,790
-52,834
-25% -$1.26M
FRO icon
2255
Frontline
FRO
$8.85B
$3.9M ﹤0.01%
545,148
+4,725
+0.9% +$32.6K
FSP
2256
Franklin Street Properties
FSP
$46.8M
$3.9M ﹤0.01%
714,745
+29,536
+4% +$147K
ADTN icon
2257
Adtran
ADTN
$616M
$3.89M ﹤0.01%
233,178
+1,273
+0.5% +$21.4K
YMAB
2258
DELISTED
Y-mAbs Therapeutics
YMAB
$3.88M ﹤0.01%
128,337
+1,967
+2% +$80.6K
PLAB icon
2259
Photronics
PLAB
$1.93B
$3.88M ﹤0.01%
301,484
-1,552
-0.5% -$18.8K
BPYU
2260
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$3.87M ﹤0.01%
215,790
-3,986
-2% -$70.7K
MITK icon
2261
Mitek Systems
MITK
$834M
$3.87M ﹤0.01%
265,578
+3,468
+1% +$55.7K
EFA icon
2262
iShares MSCI EAFE ETF
EFA
$80.2B
$3.86M ﹤0.01%
50,858
-23,745
-32% -$1.79M
WLL
2263
DELISTED
Whiting Petroleum Corporation
WLL
$3.85M ﹤0.01%
108,606
IIIV icon
2264
i3 Verticals
IIIV
$342M
$3.84M ﹤0.01%
123,453
+1,530
+1% +$48.7K
JYNT icon
2265
The Joint Corp
JYNT
$119M
$3.84M ﹤0.01%
79,382
-820
-1% -$30.7K
CCCC icon
2266
C4 Therapeutics
CCCC
$412M
$3.82M ﹤0.01%
103,314
+78,690
+320% +$3.13M
TBI
2267
Trueblue
TBI
$311M
$3.81M ﹤0.01%
173,144
+2,481
+1% +$50.9K
ASAN icon
2268
Asana
ASAN
$2.13B
$3.81M ﹤0.01%
133,328
+2,615
+2% +$90.3K
NIC icon
2269
Nicolet Bankshares
NIC
$3.62B
$3.79M ﹤0.01%
45,396
-335
-0.7% -$25.5K
GTS
2270
DELISTED
Triple-S Management Corporation
GTS
$3.78M ﹤0.01%
145,246
+1,835
+1% +$45.3K
LVO icon
2271
LiveOne
LVO
$58.2M
$3.78M ﹤0.01%
87,075
+56,272
+183% +$2.4M
CLBK icon
2272
Columbia Financial
CLBK
$1.13B
$3.76M ﹤0.01%
215,266
-34,246
-14% -$568K
AVXL icon
2273
Anavex Life Sciences
AVXL
$310M
$3.76M ﹤0.01%
251,607
+49,915
+25% +$545K
TPC
2274
Tutor Perini Cor
TPC
$5.21B
$3.76M ﹤0.01%
198,356
-276
-0.1% -$4.67K
AXDX
2275
DELISTED
Accelerate Diagnostics
AXDX
$3.76M ﹤0.01%
45,155
+790
+2% +$80.1K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.